首页> 外文期刊>International Journal of Pharmaceutics >Gastro-floating tablets of cephalexin: preparation and in vitro/in vivo evaluation.
【24h】

Gastro-floating tablets of cephalexin: preparation and in vitro/in vivo evaluation.

机译:头孢氨苄的胃漂浮片剂:制备及体外/体内评价。

获取原文
获取原文并翻译 | 示例
           

摘要

Gastro-floating tablets of cephalexin were developed to prolong the residence time in major absorption sites. Gastro-floating tablets were prepared and optimized using hydroxypropyl methylcellulose (HPMC K100M) as matrix and sodium bicarbonate as a gas-forming agent. The properties of the tablets in terms of floating lag time, floating time and in vitro release were evaluated. Furthermore, in vivo pharmacokinetic study in fed and fasted beagle dogs was performed. The gastro-floating tablets had short floating lag time and exhibited a satisfactory sustained-release profile in vitro. Compared with conventional capsules, the gastro-floating tablets presented a sustained-release behavior with a relative bioavailability of 99.4%, while the reference sustained-release tablets gave a relative bioavailability of only 39.3%. Meanwhile, the food had significant effect on the pharmacokinetics of sustained-release tablets. It was concluded that the gastro-floating tablets had a sustained-release effect in vitro and in vivo, as well as desired pharmacokinetic properties in both fed and fasted conditions.
机译:开发了头孢氨苄的胃漂浮片剂以延长在主要吸收部位的停留时间。使用羟丙基甲基纤维素(HPMC K100M)作为基质和碳酸氢钠作为气体形成剂来制备和优化胃漂浮片剂。评价了片剂的漂浮滞后时间,漂浮时间和体外释放的性质。此外,在喂食和禁食的比格犬中进行了体内药代动力学研究。胃漂浮片剂具有短的漂浮滞后时间并且在体外表现出令人满意的持续释放特性。与常规胶囊相比,胃浮片剂具有99.4%的相对生物利用度的持续释放行为,而参比的缓释片剂仅具有39.3%的相对生物利用度。同时,该食物对缓释片剂的药代动力学有显着影响。结论是,胃漂浮片剂在进食和禁食条件下均具有体外和体内的缓释作用,以及所需的药代动力学特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号